At its annual shareholder meeting last week, CytRx said that it has appointed Richard Wennekamp and Marvin Selter to its board of directors.
Wennekamp and Selter replace outgoing members Raymond Carnahan and Herbert McDade.
Richard Wennekamp, Marvin Selter, Raymond Carnahan, Herbert McDade, Gerald Ford, and Brenda Bass
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.